RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Baltimore, MD · +173 more sites
4 recruiting breast cancer studies with a site in Columbia, MD.
Sponsor: Stemline Therapeutics, Inc.
Baltimore, MD · +173 more sites
Sponsor: NRG Oncology
Baltimore, MD · +378 more sites
Sponsor: NRG Oncology
Baltimore, MD · +809 more sites
Sponsor: SCRI Development Innovations, LLC
Columbia, MD · +7 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.